Literature DB >> 30860015

Case Report: Hyperreactive Malarial Splenomegaly Syndrome Diagnosed with Loop-Mediated Isothermal Amplification and Treated with Artemisinin-Based Combination Therapy.

Francesco G Genderini1,2, Cecile Haeseleer3, Brigitte Cantinieaux3, Charlotte Martin2.   

Abstract

Hyperreactive malarial splenomegaly syndrome (HMSS) is a rare cause of splenomegaly in the Western world. Hyperreactive malarial splenomegaly syndrome is caused by an aberrant immunological response to chronic malaria exposure in endemic areas. Revised Fakunle's criteria may be helpful for diagnosis: persistent splenomegaly (> 10 cm below the costal margin), increased anti-Plasmodium antibodies, increased IgM levels, exclusion of other causes of splenomegaly or malignancy, and a favorable response to antimalarial treatment. We describe the case of a 16-year-old patient, who recently arrived in Belgium from Guinea with a history of splenomegaly and B symptoms in whom HMSS diagnosis was achieved, thanks to the loop-mediated isothermal amplification method. To our knowledge, this is also the first described case treated by dihydroartemisinin/piperaquine.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30860015      PMCID: PMC6493928          DOI: 10.4269/ajtmh.18-0765

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

1.  Protective effects of the sickle cell gene against malaria morbidity and mortality.

Authors:  Michael Aidoo; Dianne J Terlouw; Margarette S Kolczak; Peter D McElroy; Feiko O ter Kuile; Simon Kariuki; Bernard L Nahlen; Altaf A Lal; Venkatachalam Udhayakumar
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

2.  Sickle cell disease and hyperreactive malarial splenomegaly (HMS) in young immigrants from Africa.

Authors:  Lucia De Franceschi; Simona Sada; Annalisa Andreoli; Andrea Angheben; Stefania Marocco; Zeno Bisoffi
Journal:  Blood       Date:  2005-12-15       Impact factor: 22.113

3.  Review of diagnostic criteria of hyper-reactive malarial splenomegaly.

Authors:  I Bates; G Bedu-Addo
Journal:  Lancet       Date:  1997-04-19       Impact factor: 79.321

4.  Mortality in tropical splenomegaly syndrome.

Authors:  Y M Fakunle; B M Greenwood
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

5.  The use of PCR in the diagnosis of hyper-reactive malarial splenomegaly (HMS).

Authors:  S Puente; J M Rubio; M Subirats; M Lago; J Gonzalez-Lahoz; A Benito
Journal:  Ann Trop Med Parasitol       Date:  2000-09

6.  [Hyperreactive malarial splenomegaly: three clinical cases and literature review].

Authors:  B Camara; J-B Kantambadouno; G Martin-Blondel; A Berry; M Alvarez; F Benoit-Vical; J Delmont; O Bouchaud; B Marchou
Journal:  Med Mal Infect       Date:  2008-10-25       Impact factor: 2.152

7.  A case of hyper-reactive malarial splenomegaly. The role of rapid antigen-detecting and PCR-based tests.

Authors:  B Mothe; J Lopez-Contreras; O H Torres; C Muñoz; P Domingo; M Gurgui
Journal:  Infection       Date:  2007-09-28       Impact factor: 3.553

Review 8.  Tropical splenomegaly. Part 1: Tropical Africa.

Authors:  Y M Fakunle
Journal:  Clin Haematol       Date:  1981-10

9.  Hyper-reactive malarial splenomegaly in a patient with human immunodeficiency virus.

Authors:  G De Iaco; N Saleri; F Perandin; M Gulletta; G Ravizzola; N Manca; L Signorini; A Matteelli; K Prestini; F Castelli
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

10.  Diagnostic accuracy of loop-mediated isothermal amplification (LAMP) for screening patients with imported malaria in a non-endemic setting.

Authors:  Camille Ponce; Flora Kaczorowski; Thomas Perpoint; Patrick Miailhes; Alain Sigal; Etienne Javouhey; Yves Gillet; Laurent Jacquin; Marion Douplat; Karim Tazarourte; Véronique Potinet; Bruno Simon; Adeline Lavoignat; Guillaume Bonnot; Fatimata Sow; Anne-Lise Bienvenu; Stéphane Picot
Journal:  Parasite       Date:  2017-12-18       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.